Ascendis Pharma A (ASND) Prepaid Assets (2012 - 2026)
Ascendis Pharma A (ASND) reported Prepaid Assets of $45.2 million for Q1 2026, up 27.49% on a YoY basis from $35.4 million in Q1 2025, and up 15.06% sequentially from $39.2 million in Q4 2025.
Ascendis Pharma A (ASND) Prepaid Assets (2012 - 2026) Analysis & Trends
Ascendis Pharma A (ASND) has 15 years of Prepaid Assets data on file, last reported at $45.2 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets rose 27.49% year-over-year to $45.2 million; the trailing twelve-month figure through Mar 2026 stood at $45.2 million (up 27.49% YoY), and the FY2025 full-year result was $39.2 million, up 28.27% from the prior year.
- Prepaid Assets grew to $45.2 million in Q1 2026, from $39.2 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $46.8 million in Q2 2023 to a low of $30.2 million in Q4 2024.
- A 5-year average of $38.4 million and a median of $38.8 million in 2025 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets soared 70.0% in 2022 and dropped 27.22% in 2024, its largest moves.
- Tracing ASND's Prepaid Assets over 5 years: stood at $32.4 million in 2022, then rose by 28.27% to $41.5 million in 2023, then dropped by 27.22% to $30.2 million in 2024, then gained by 29.92% to $39.2 million in 2025, then gained by 15.06% to $45.2 million in 2026.
- Business Quant data shows ASND's Prepaid Assets at $45.2 million in Q1 2026, $39.2 million in Q4 2025, and $34.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Ascendis Pharma A | 15.31 Bn | 14.64 Bn | 268.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 45.16 Mn |
| Dec 31, 2025 | 39.25 Mn |
| Sep 30, 2025 | 34.39 Mn |
| Jun 30, 2025 | 38.84 Mn |
| Mar 31, 2025 | 35.42 Mn |
| Dec 31, 2024 | 30.21 Mn |
| Sep 30, 2024 | 35.63 Mn |
| Jun 30, 2024 | 39.57 Mn |
| Mar 31, 2024 | 46.17 Mn |
| Dec 31, 2023 | 41.51 Mn |
| Sep 30, 2023 | 41.72 Mn |
| Jun 30, 2023 | 46.78 Mn |
| Mar 31, 2023 | 41.53 Mn |
| Dec 31, 2022 | 32.36 Mn |
| Sep 30, 2022 | 34.85 Mn |
| Jun 30, 2022 | 37.42 Mn |
| Mar 31, 2022 | 31.42 Mn |
| Dec 31, 2021 | 28.86 Mn |
| Sep 30, 2021 | 26.23 Mn |
| Jun 30, 2021 | 26.28 Mn |